Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “NASH Fibrosis”

304 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 304 results

Large-scale testing (Phase 3)Study completedNCT01051219
What this trial is testing

Anti-Fibrotic Effects of Losartan In Nash Evaluation Study

Who this might be right for
Nonalcoholic Steatohepatitis
Newcastle-upon-Tyne Hospitals NHS Trust 45
Not applicableLooking for participantsNCT04371042
What this trial is testing

PROtocol of Metabolic and Cryptogenic livEr Disease regisTry for intEgration of Omic Studies

Who this might be right for
NAFLD - Nonalcoholic Fatty Liver DiseaseDiabetesObesity+6 more
Fondazione Policlinico Universitario Agostino Gemelli IRCCS 5,000
Large-scale testing (Phase 3)Study completedNCT00244569
What this trial is testing

Development of a Breath Test for Monitoring Patients With Liver Disease

Who this might be right for
Fatty LiverCirrhosis
Virginia Commonwealth University 120
Not applicableLooking for participantsNCT05699018
What this trial is testing

Screening in Primary Care of Advanced Liver Fibrosis in NAFLD And/or Alcoholic Patients

Who this might be right for
Non-alcoholic Fatty Liver Disease (NAFLD)Alcoholic Liver Disease (ALD)Liver Fibrosis
University Hospital, Angers 1,788
Not applicableStudy completedNCT02679417
What this trial is testing

The Effects of Type of Exercise in Non-alcoholic Fatty Liver Disease

Who this might be right for
Non-alcoholic Fatty Liver Disease
Mahidol University 38
Not applicableEnded earlyNCT03534141
What this trial is testing

Mild Hypothermia and Acute Kidney Injury in Liver Transplantation

Who this might be right for
CirrhosisEnd Stage Liver DiseaseAcute Kidney Injury+7 more
University of California, San Francisco 175
Not applicableLooking for participantsNCT05309863
What this trial is testing

Comparison Between the Efficacy of Residential and Ambulatory Weight Loss Programs for Pediatric Non-alcoholic Fatty Liver Disease

Who this might be right for
Pediatric Non-alcoholic Fatty Liver Disease
University Hospital, Ghent 850
Not applicableStudy completedNCT04573543
What this trial is testing

The Role of Immune Semaphorins in NAFLD

Who this might be right for
Non-Alcoholic Fatty Liver DiseaseImmune ResponseBiomarkers+2 more
University Hospital for Infectious Diseases, Croatia 160
Testing effectiveness (Phase 2)WithdrawnNCT04607655
What this trial is testing

Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Orally Administered GB1211 in Participants With Suspected or Confirmed Non-alcoholic Steatohepatitis (NASH) and Liver Fibrosis

Who this might be right for
Non-alcoholic Steatohepatitis (NASH)
Galecto Biotech AB
Not applicableStudy completedNCT03198104
What this trial is testing

Assessing Kids for Liver Inflammation and Fibrosis Using Non-invasive MRI

Who this might be right for
Non-alcoholic SteatohepatitisLiver DiseasesLiver Fibroses+2 more
Perspectum 35
Not applicableLooking for participantsNCT06519162
What this trial is testing

Liver-gut Axis Study Through Identification of Liver Disease-specific Microbiome

Who this might be right for
Autoimmune HepatitisPrimary Sclerosing CholangitisNon-Alcoholic Fatty Liver Disease+2 more
Chungnam National University Hospital 3,000
Not applicableNot Yet RecruitingNCT04925362
What this trial is testing

THE FRENCH NATIONAL NAFLD COHORT (FRench pAtients With MEtabolic Steatosis)

Who this might be right for
NAFLDNASHNASH - Nonalcoholic Steatohepatitis+2 more
Assistance Publique - Hôpitaux de Paris 900
Not applicableUnknownNCT05971082
What this trial is testing

Risk Factors for Advanced Fibrosis Among FLD Patients

Who this might be right for
NAFLDLiver CirrhosisDiabetes Mellitus, Type 2
Helsinki University Central Hospital 1,000
Testing effectiveness (Phase 2)Active Not RecruitingNCT05402371
What this trial is testing

Evaluate the Efficacy and Safety of Rencofilstat in Subjects With NASH and Advanced Liver Fibrosis

Who this might be right for
Nonalcoholic Steatohepatitis (NASH)Fibrosis, LiverNAFLD
Hepion Pharmaceuticals, Inc. 120
Not applicableEnded earlyNCT01629095
What this trial is testing

Genetic Studies of Non-Alcoholic Fatty Liver Disease

Who this might be right for
Non-Alcoholic Steato-HepatitisLiver CirrhosisNon-Alcoholic Fatty Liver Disease
National Human Genome Research Institute (NHGRI) 17
Large-scale testing (Phase 3)Study completedNCT02030977
What this trial is testing

The Effects of Resveratrol Supplement on Biochemical Factors and Hepatic Fibrosis in Patients With Nonalcoholic Steatohepatitis

Who this might be right for
Non Alcoholic Fatty Liver
Dr Azita Hekmatdoost 50
Testing effectiveness (Phase 2)Study completedNCT02462967
What this trial is testing

Clinical Trial to Evaluation the Safety and Efficacy of GR-MD-02 for the Treatment of Liver Fibrosis and Resultant Portal Hypertension in Patients With Nash Cirrhosis

Who this might be right for
Hypertension, Portal
Galectin Therapeutics Inc. 162
Not applicableLooking for participantsNCT03572465
What this trial is testing

Quantitative Ultrasound Techniques for Diagnosis of Nonalcoholic Steatohepatitis

Who this might be right for
Nonalcoholic Fatty Liver Disease (NAFLD)Nonalcoholic Steatohepatitis (NASH)
Centre hospitalier de l'Université de Montréal (CHUM) 102
Testing effectiveness (Phase 2)Looking for participantsNCT05648214
What this trial is testing

A Trial to Learn if ALN-PNP is Safe and Well Tolerated in Healthy Adults and Adult Participants With Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)

Who this might be right for
Healthy VolunteersMetabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)
Regeneron Pharmaceuticals 172
Testing effectiveness (Phase 2)Study completedNCT05638737
What this trial is testing

A Study in Participants With Non-cirrhotic NASH With Fibrosis

Who this might be right for
Non-Cirrhotic Non-alcoholic Steatohepatitis With Fibrosis
AstraZeneca 112
Load More Results